Stocks
Intellia Therapeutics (NTLA) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -100.8 | -136.6 | -267.9 | -444.7 | -506.2 | -512.4 | ||
| Changes by years, y/y, % | +11% | +36% | +96% | +66% | +14% | +41.0% | |||
Intellia Therapeutics. EBITDA US GAAP, bln rub
Intellia Therapeutics. EBITDA US GAAP, changes, %
Intellia Therapeutics. EBITDA US GAAP, sum by quarters, bln rub
Intellia Therapeutics (NTLA) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| EBITDA, bln rub | ? | -111.9 | -132.3 | -131.1 | -137.4 | -111.5 | -512.4 | |
| Changes by years, y/y, % | -21% | +34% | +37% | +31% | 0% | |||
| Changes by quarters, q/q, % | +7% | +18% | -1% | +5% | -19% | |||
